Blood analyzer, blood analysis method, and computer program product

Patent metadata

Field	Value
Publication number	US-2016202170-A1
Application number	US-201615074068-A
Country	US
Kind code	A1
Filing date	Mar 18, 2016
Priority date	Apr 28, 2011
Publication date	Jul 14, 2016
Grant date	—

Abstract

A blood analyzer, a blood analysis method, and a computer program that can distinguishably detect abnormal lymphocytes from blasts and atypical lymphocytes are provided. A blood analyzer includes a sample preparation portion configured to prepare first and second measurement samples. A light source is configured to irradiate the first and second measurement samples. A light receiving portion is configured to receive fluorescence and scattered light from cells in the first and measurement samples. A cell analysis portion is configured to perform a first detection process to detect abnormal lymphocytes and a second detection process to detect nucleated erythrocytes. The cell analysis portion determines whether abnormal lymphocytes are present in a blood specimen based on the results of the first and detection processes.

First claim

1 . A blood analyzer comprising:
a sample preparation portion configured to prepare a first measurement sample from a blood specimen and a first reagent and prepare a second measurement sample from a blood specimen and a second reagent; a light source configured to irradiate the first measurement sample and the second measurement sample with light; a light receiving portion configured to receive fluorescence and scattered light from cells in the first measurement sample which is irradiated with light by the light source to output a first fluorescence signal relating to the received fluorescence and a first scattered light signal relating to the received scattered light, and configured to receive fluorescence and scattered light from cells in the second measurement sample which is irradiated with light by the light source to output a second fluorescence signal relating to the received fluorescence and a second scattered light signal relating to the received scattered light; and a cell analysis portion configured to perform a first detection process to detect abnormal lymphocytes based on the first fluorescence signal and the first scattered light signal, and a second detection process to detect nucleated erythrocytes based on the second fluorescence signal and the second scattered light signal; wherein the cell analysis portion is configured to perform a determination process for determining whether abnormal lymphocytes are present in a blood specimen based on the results of the first detection process and the second detection process.

2 . The blood analyzer according to claim 1 further comprising an output portion configured to output the detection results by the cell analysis portion, wherein the cell analysis portion is configured to control the output portion to output information indicating the possibility that abnormal lymphocytes are present based on the results of the determination process.

3 . The blood analyzer according to claim 2 , wherein the cell analysis portion is configured to:
obtain a value reflecting the number of the abnormal lymphocytes based on the first fluorescence signal and the first scattered light signal and compare the obtained value and a first threshold, and
obtain a value reflecting the number of the nucleated erythrocytes based on the second fluorescence signal and the second scattered light signal and compares the obtained value and a second threshold.

4 . The blood analyzer according to claim 3 , wherein in the case that the value reflecting the number of the abnormal lymphocytes is greater than the first threshold and the value reflecting the number of the nucleated erythrocytes is smaller than the second threshold, the cell analysis portion controls the output portion to output information indicating the possibility that abnormal lymphocytes are present.

5 . The blood analyzer according to claim 3 , wherein in the case that the value reflecting the number of the abnormal lymphocytes is greater than the first threshold and the value reflecting the number of the nucleated erythrocytes is greater than the second threshold, the cell analysis portion controls the output portion to output information indicating the possibility that nucleated erythrocytes are present.

6 . The blood analyzer according to claim 3 , wherein in the case that the value reflecting the number of the abnormal lymphocytes is greater than the first threshold and the value reflecting the number of the nucleated erythrocytes is greater than the second threshold, the cell analysis portion controls the output portion not to output information indicating the possibility that abnormal lymphocytes are present.

7 . The blood analyzer according to claim 1 , wherein the first reagent is a hemolyzing agent to distinguishably detect abnormal lymphocytes, atypical lymphocytes and blasts.

8 . The blood analyzer according to claim 1 , wherein the first reagent contains a nonionic surfactant and does not substantially contain a cationic surfactant.

9 . The blood analyzer according to claim 1 , wherein the second reagent is a hemolyzing agent to detect nucleated erythrocytes.

10 . The blood analyzer according to claim 1 , wherein the cell analysis portion is configured to detect cells in an area with a fluorescence intensity higher than that in the area where lymphocytes and monocytes appear, as abnormal lymphocytes cells.

11 . A blood analysis method comprising:
preparing a first measurement sample from a blood specimen and a first reagent; irradiating the first measurement sample with light; receiving fluorescence and scattered light that are produced from cells in the first measurement sample which is irradiated with light to obtain a first fluorescence signal relating to the received fluorescence and a first scattered light signal relating to the received scattered light; preparing a second measurement sample from a blood specimen and a second reagent; irradiating the second measurement sample with light; receiving fluorescence and scattered light that are produced from cells in the second measurement sample which is irradiated with light to obtain a second fluorescence signal relating to the received fluorescence and a second scattered light signal relating to the received scattered light; detecting abnormal lymphocytes based on the first fluorescence signal and the first scattered light signal; detecting nucleated erythrocytes based on the second fluorescence signal and the second scattered light signal; and determining whether abnormal lymphocytes are present in a blood specimen based on the detection results of the detecting nucleated erythrocytes and detecting nucleated erythrocytes.

12 . The blood analysis method according to claim 11 , further comprising outputting information indicating the possibility that abnormal lymphocytes are present based on the results of the determining process.

13 . The blood analysis method according to claim 12 , further comprising:
obtaining a value reflecting the number of the abnormal lymphocytes based on the first fluorescence signal and the first scattered light signal; comparing the obtained value and a first threshold; obtaining a value reflecting the number of the nucleated erythrocytes based on the second fluorescence signal and the second scattered light signal; and comparing the obtained value and a second threshold.

14 . The blood analysis method according to claim 13 , further comprising in the case that the value reflecting the number of the abnormal lymphocytes is greater than the first threshold and the value reflecting the number of the nucleated erythrocytes is smaller than the second threshold, outputting information indicating the possibility that abnormal lymphocytes are present.

15 . The blood analysis method according to claim 13 , further comprising in the case that the value reflecting the number of the abnormal lymphocytes is greater than the first threshold and the value reflecting the number of the nucleated erythrocytes is greater than the second threshold, outputting information indicating the possibility that nucleated erythrocytes are present.

16 . The blood analysis method according to claim 13 , further comprising in the case that the value reflecting the number of the abnormal lymphocytes is greater than the first threshold and the value reflecting the number of the nucleated erythrocytes is greater than the second threshold, not outputting information indicating the possibility that abnormal lymphocytes are present.

17 . The blood analysis method according to claim 11 , wherein the

Assignees

• Sysmex Corp

Inventors

• Yoshida Ayumu
• Kataoka Yukiko
• Tsuji Tomohiro

Classifications

• G01N21/6428

  Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title

• G01N2021/6439

  with indicators, stains, dyes, tags, labels, marks · CPC title

• G01N15/14 Primary

  Optical investigation techniques, e.g. flow cytometry · CPC title

• G01N21/49

  within a body or fluid · CPC title

• G01N33/5005

  involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025) · CPC title